Pharmacology of a non‐selective ETA and ETB receptor antagonist, TAK‐044 and the inhibition of myocardial infarct size in rats
Authors:
Open Access
- 1 March 1995
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 114 (5) , 949-954
Abstract
The aims of the present study were to characterize the pharmacological profile of a new endothelin (ET) receptor antagonist, TAK‐044 and to consider whether it limits the extension of myocardial infarct size in rats. Binding of [125I]‐ET‐1 to ET receptors on rabbit ventricular and cerebellar membrane fractions was inhibited by TAK‐044 with IC50 values of 3.8 nm and 130 nm, respectively. It inhibited ET‐1, ET‐2 and ET‐3‐induced vasoconstriction of porcine isolated coronary arteries in a competitive (ET‐1, ET‐2) and a non‐competitive (ET‐3) manner. In the rat in vivo, the ET‐1‐induced blood pressure changes including transient hypotension followed by sustained hypertension, were inhibited by TAK‐044 (0.1–10 mg kg−1, i.v.) in a dose‐dependent manner. Acute myocardial infarction induced by 1 h coronary occlusion followed by 24 h reperfusion in rats caused an infarct size of 60 ± 2% (n = 12) of the area‐at‐risk by weight. Intravenous injection of TAK‐044 10 min before coronary occlusion reduced the infarct size in a dose‐dependent manner: 32% and 54% reductions at 1 and 3 mg kg−1, respectively. TAK‐044 administered 10 min before or 1 h after reperfusion (1 mg kg−1, i.v.) showed similar inhibitory effects: 34% and 23% reductions, respectively. We conclude that TAK‐044 is an ETA/ETB receptor antagonist which shows strong inhibitory effects on the extension of myocardial infarct size after coronary artery occlusion‐reperfusion in rats.Keywords
This publication has 34 references indexed in Scilit:
- Cyclic Hexapeptide Endothelin Receptor Antagonists Highly Potent for Both Receptor Subtypes ETA and ETBBiochemical and Biophysical Research Communications, 1994
- Effects of a new endothelin antagonist, TAK-044, on post-ischemic acute renal failure in ratsLife Sciences, 1994
- Endothelin-1 and Endothelin Receptor mRNA Expression in Normal and Atherosclerotic Human ArteriesBiochemical and Biophysical Research Communications, 1993
- A novel subtype of endothelin B receptor mediating contraction in swine pulmonary veinLife Sciences, 1993
- Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptorLife Sciences, 1992
- Sarafotoxin S6c: An agonist which distinguishes between endothelin receptor subtypesBiochemical and Biophysical Research Communications, 1991
- Increased Plasma Endothelin Level in Patients with Essential HypertensionNew England Journal of Medicine, 1990
- Pathophysiological role of endothelin in acute renal failureLife Sciences, 1990
- Outbreak of Asthma Associated with Soybean DustNew England Journal of Medicine, 1989
- Plasma Endothelin Levels in Patients with Acute Renal FailureNew England Journal of Medicine, 1989